American Journal of Epidemiology Advance Access originally published online on March 30, 2009
American Journal of Epidemiology 2009 169(10):1279; doi:10.1093/aje/kwp048
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Journal of Epidemiology © The Author 2009. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.
LETTERS TO THE EDITOR |
THE AUTHORS REPLY
1 Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720
2 Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA 94107
3 Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, CA 94720
(e-mail: neela@berkeley.edu)
| The first 10% of the full text of this article appears below. |
We appreciate the opportunity to address the 2 concerns raised by Drs. Lanciotti and Dufour (1) regarding our Human Genome Epidemiology review and meta-analysis on NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphisms and childhood leukemia (2).
Lanciotti and Dufour's first point pertains to 2 case-only studies (3, 4) noted in